-
1
-
-
0032559775
-
Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study
-
10.1001/archinte.158.6.585, 9521222
-
Silverstein MD, Heit JA, Mohr DN, Petterson TM, OFallon WM, Melton LJ. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998, 158:585-593. 10.1001/archinte.158.6.585, 9521222.
-
(1998)
Arch Intern Med
, vol.158
, pp. 585-593
-
-
Silverstein, M.D.1
Heit, J.A.2
Mohr, D.N.3
Petterson, T.M.4
O'Fallon, W.M.5
Melton, L.J.6
-
2
-
-
0034023924
-
Incidence of venous thromboembolism: a community-based study in western France. EPI-GETBP study group. Groupe d'Etude de la thrombose de Bretagne occidentale
-
Oger E. Incidence of venous thromboembolism: a community-based study in western France. EPI-GETBP study group. Groupe d'Etude de la thrombose de Bretagne occidentale. Thromb Haemost 2000, 83:657-660.
-
(2000)
Thromb Haemost
, vol.83
, pp. 657-660
-
-
Oger, E.1
-
3
-
-
0032507023
-
Risk of fatal pulmonary embolism in patients with treated venous thromboembolism
-
10.1001/jama.279.6.458, 9466640
-
Douketis JD, Kearon C, Bates S, Duku EK, Ginsberg JS. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA 1998, 279:458-462. 10.1001/jama.279.6.458, 9466640.
-
(1998)
JAMA
, vol.279
, pp. 458-462
-
-
Douketis, J.D.1
Kearon, C.2
Bates, S.3
Duku, E.K.4
Ginsberg, J.S.5
-
4
-
-
50549183274
-
Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial
-
Barritt DW, Jordan SC. Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial. Lancet 1960, 1:1309-1312.
-
(1960)
Lancet
, vol.1
, pp. 1309-1312
-
-
Barritt, D.W.1
Jordan, S.C.2
-
5
-
-
84856802635
-
Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines
-
3278049, 22315268
-
Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, Nelson ME, Wells PS, Gould MK, Dentali F, Crowther M, Kahn SR. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 2012, 141:e419S-e494S. 3278049, 22315268.
-
(2012)
Chest
, vol.141
-
-
Kearon, C.1
Akl, E.A.2
Comerota, A.J.3
Prandoni, P.4
Bounameaux, H.5
Goldhaber, S.Z.6
Nelson, M.E.7
Wells, P.S.8
Gould, M.K.9
Dentali, F.10
Crowther, M.11
Kahn, S.R.12
-
6
-
-
77649149260
-
Rivaroxaban: a new oral factor Xa inhibitor
-
10.1161/ATVBAHA.110.202978, 20139357
-
Perzborn E, Roehrig S, Straub A, Kubitza D, Mueck W, Laux V. Rivaroxaban: a new oral factor Xa inhibitor. Arterioscler Thromb Vasc Biol 2010, 30:376-381. 10.1161/ATVBAHA.110.202978, 20139357.
-
(2010)
Arterioscler Thromb Vasc Biol
, vol.30
, pp. 376-381
-
-
Perzborn, E.1
Roehrig, S.2
Straub, A.3
Kubitza, D.4
Mueck, W.5
Laux, V.6
-
7
-
-
74249121331
-
Safety, pharmacokinetics and pharmacodynamics of single doses of rivaroxaban - an oral, direct factor Xa inhibitor - in elderly Chinese subjects
-
Jiang J, Hu Y, Zhang J, Yang J, Mueck W, Kubitza D, Bauer RJ, Meng L, Hu P. Safety, pharmacokinetics and pharmacodynamics of single doses of rivaroxaban - an oral, direct factor Xa inhibitor - in elderly Chinese subjects. Thromb Haemost 2010, 103:234-241.
-
(2010)
Thromb Haemost
, vol.103
, pp. 234-241
-
-
Jiang, J.1
Hu, Y.2
Zhang, J.3
Yang, J.4
Mueck, W.5
Kubitza, D.6
Bauer, R.J.7
Meng, L.8
Hu, P.9
-
8
-
-
78650619315
-
Oral rivaroxaban for symptomatic venous thromboembolism
-
The EINSTEIN Investigators
-
The EINSTEIN Investigators Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med 2010, 363:2499-2510. The EINSTEIN Investigators.
-
(2010)
N Engl J Med
, vol.363
, pp. 2499-2510
-
-
-
9
-
-
84859385808
-
Oral rivaroxaban for the treatment of symptomatic pulmonary embolism
-
The EINSTEIN-PE Investigators
-
The EINSTEIN-PE Investigators Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med 2012, 366:1287-1297. The EINSTEIN-PE Investigators.
-
(2012)
N Engl J Med
, vol.366
, pp. 1287-1297
-
-
-
10
-
-
84879822413
-
Derivation of the non-inferiority margin for the evaluation of direct oral anticoagulants in the treatment of venous thromboembolism
-
10.1186/1477-9560-11-13, 3710481, 23829521
-
Prins MH, Lensing AWA. Derivation of the non-inferiority margin for the evaluation of direct oral anticoagulants in the treatment of venous thromboembolism. Thromb J 2013, 11:13. 10.1186/1477-9560-11-13, 3710481, 23829521.
-
(2013)
Thromb J
, vol.11
, pp. 13
-
-
Prins, M.H.1
Lensing, A.W.A.2
-
11
-
-
84884336961
-
Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies
-
10.1186/1477-9560-11-21, 3850944, 24053656, on behalf of the EINSTEIN Investigators
-
Prins MH, Lensing AWA, Bauersachs R, van Bellen B, Bounameaux H, Brighton TA, Cohen AT, Davidson BL, Decousus H, Raskob GE, Berkowitz SD, Wells PS. on behalf of the EINSTEIN Investigators Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies. Thromb J 2013, 11:21. 10.1186/1477-9560-11-21, 3850944, 24053656, on behalf of the EINSTEIN Investigators.
-
(2013)
Thromb J
, vol.11
, pp. 21
-
-
Prins, M.H.1
Lensing, A.W.A.2
Bauersachs, R.3
van Bellen, B.4
Bounameaux, H.5
Brighton, T.A.6
Cohen, A.T.7
Davidson, B.L.8
Decousus, H.9
Raskob, G.E.10
Berkowitz, S.D.11
Wells, P.S.12
-
12
-
-
33750474106
-
Incidence of deep vein thrombosis in hospitalized Chinese medical patients is similar to that in Western populations
-
10.1016/j.thromres.2005.12.014, 16460786
-
Leung V, Leung V, Lui W, Chan T, Wong RS, Cheng G. Incidence of deep vein thrombosis in hospitalized Chinese medical patients is similar to that in Western populations. Thromb Res 2006, 118:763-764. 10.1016/j.thromres.2005.12.014, 16460786.
-
(2006)
Thromb Res
, vol.118
, pp. 763-764
-
-
Leung, V.1
Leung, V.2
Lui, W.3
Chan, T.4
Wong, R.S.5
Cheng, G.6
-
13
-
-
84875282368
-
Incidence of deep vein thrombosis in hospitalized Chinese medical patients and the impact of DVT prophylaxis
-
3211080, 22084666
-
Cheng G, Chan C, Liu YT, Choy YF, Wong MM, Yeung PK, Ng KL, Tsang LS, Wong RS. Incidence of deep vein thrombosis in hospitalized Chinese medical patients and the impact of DVT prophylaxis. Thrombosis 2011, 2011:629383. 3211080, 22084666.
-
(2011)
Thrombosis
, vol.2011
, pp. 629383
-
-
Cheng, G.1
Chan, C.2
Liu, Y.T.3
Choy, Y.F.4
Wong, M.M.5
Yeung, P.K.6
Ng, K.L.7
Tsang, L.S.8
Wong, R.S.9
-
14
-
-
18244400400
-
Is INR between 2.0 and 3.0 the optimal level for Chinese patients on warfarin therapy for moderate-intensity anticoagulation?
-
10.1111/j.1365-2125.2005.02361.x, 1884850, 15842557
-
You JH, Chan FW, Wong RS, Cheng G. Is INR between 2.0 and 3.0 the optimal level for Chinese patients on warfarin therapy for moderate-intensity anticoagulation?. Br J Clin Pharmacol 2005, 59:582-587. 10.1111/j.1365-2125.2005.02361.x, 1884850, 15842557.
-
(2005)
Br J Clin Pharmacol
, vol.59
, pp. 582-587
-
-
You, J.H.1
Chan, F.W.2
Wong, R.S.3
Cheng, G.4
-
15
-
-
1942485404
-
Hemorrhagic complications of anticoagulant therapy in Chinese patients
-
Chan TY, Miu KY. Hemorrhagic complications of anticoagulant therapy in Chinese patients. J Chin Med Assoc 2004, 67:55-62.
-
(2004)
J Chin Med Assoc
, vol.67
, pp. 55-62
-
-
Chan, T.Y.1
Miu, K.Y.2
-
16
-
-
0033638222
-
Long-term treatment with warfarin in Chinese population
-
Chenhsu RY, Chiang SC, Chou MH, Lin MF. Long-term treatment with warfarin in Chinese population. Ann Pharmacother 2000, 34:1395-1401.
-
(2000)
Ann Pharmacother
, vol.34
, pp. 1395-1401
-
-
Chenhsu, R.Y.1
Chiang, S.C.2
Chou, M.H.3
Lin, M.F.4
|